Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Vaccine Safety Documentary Widens Release to Europe Despite Censorship Attempts

Filmmaker Joins Robert Kennedy Jr. and Robert De Niro on Stage at National Press Club for a Groundbreaking Press Conference


News provided by

Cinema Libre Studio

Feb 17, 2017, 11:15 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Feb. 17, 2017 /PRNewswire/ -- America's most controversial documentary, Vaxxed: From Cover-Up to Catastrophe from Cinema Libre Studios, premiered in Belgium, the U.K and France over this last week despite significant censorship attempts by some members of the European Parliament, by Parisian government officials, and a U.K. cinema owner. At the same time, Del Bigtree, one of the producers of Vaxxed, joined Robert F. Kennedy, Jr. and Robert De Niro at the National Press Club to announce a $100,000 challenge with the goal of stopping the use of mercury in vaccines.

Continue Reading
Cinema Libre Studio
Cinema Libre Studio

Vaxxed investigates the charges made by a whistleblower at the Centers for Disease Control and Prevention, the leading national public health institute of the United States, who revealed that the agency manipulated and destroyed data on an important study showing a causal link between the Measles-Mumps-Rubella (MMR) vaccine and autism. The film, which calls for safer vaccines, was released in 2016 in North America amidst significant controversy for its criticism of the CDC and the pharmaceutical industry.

Vaxxed was scheduled to screen last week at the European Parliament in Brussels as part of a conference on vaccine safety, organized and hosted by a French MEP. Due to a disinformation campaign led by a small, but vocal, opposition group with purported ties to the pharmaceutical industry, some Members of the European Parliament made the decision to censor the film and prevent it from screening at the Parliament. Both the screening and this unprecedented vaccine safety conference moved locations and took place on February 9th with a discussion following that included the film's director, Dr. Andrew Wakefield, Nobel Prize winning virologist Luc Montagnier, MEP Michele Rivasi, and the Italian nanotechnology researcher Stefano Montanari.

(http://www.globalmediaplanet.info/expert-debate-held-in-bruxelles-vaccine-safety-under-questionmark/)

An additional debate on Vaccine safety was hosted in this venue on the same afternoon. Opened to the public of Brussels, this second debate lined-up several major experts on the question of vaccines safety, including lawyers, scientists and whistleblowers hailing from different European countries for the occasion. This second debate was followed by an additional screening of Vaxxed with 300 people in attendance the entire day.

A second Paris screening was scheduled for Monday, February 13th, by the same MEP, as part of a vaccine safety debate to take place at a City Hall venue in the 2ndarrondissement.  That screening was cancelled by a top Paris city official who never even saw the film. The screening and vaccine safety debate, with Wakefield in attendance, also moved to an alternate venue, with 155 people in attendance and a clear "Stop the Censure" message by the public.

"The censorship in Europe, specifically by a top Paris city official and some members of the European Parliament, continues the defamation that the team involved with the film endured in the U.S. and Australia. Those people carry an enormous responsibility by preventing an essential debate to take place while hundreds of thousands of children become sicker or fall on the autistic spectrum. We all believe in vaccines but the pharmaceutical industry does not care about vaccine safety and that is what must change. The film challenges the multibillion dollar revenue streams of the two major pharmaceutical companies that hold the majority share of the MMR vaccine market in the U.K. and U.S., which is why they are doing everything they can to stop people from seeing it," says Philippe Diaz, Chairman of Cinema Libre Studio. "Therefore, we are making Vaxxed available to stream commercially in the U.K., Ireland and Australia." (www.vaxxedthemovie.com/stream/)

In London, a premiere at the Curzon Cinemas was also cancelled due to a phone campaign organized by the same opposition group. The February 14th London premiere of Vaxxed was moved to an alternative venue and continued with director Wakefield in attendance.

Yesterday, Vaxxed producer Del Bigtree joined Robert F. Kennedy, Jr. and Robert De Niro on stage at the National Press Club in Washington D.C., as part of a World Mercury Project press conference to announce a $100,000 award to any journalist who could produce a single study that conclusively showed that it was safe to inject pregnant women and children with levels of mercury that are currently found in common vaccines.

(http://www.trueactivist.com/robert-de-niro-and-rfk-jr-expose-massive-corruption-in-vaccine-industry-in-a-press-conference/

https://www.facebook.com/WorldMercuryProject/videos/1866347393612673/ )

Vaxxed is also produced by British filmmaker Polly Tommey of the Autism Media Channel with Bigtree, who was a medical journalist with the hit television show "The Doctors."

Director Wakefield is a British academic gastroenterologist who, with Dr. John Walker-Smith, one of the world's leading pediatric gastroenterologists, was the first to postulate that there was a causal link between gut problems in regressive autistic patients and vaccines. They, along with 11 other authors, published their findings in The Lancet, a British medical journal, in February 1998. At a press conference in support of the publication, Wakefield suggested using the single measles, mumps and rubella shots, instead of the bundled three shot MMR, until further studies could be done. Upon hearing this information, some parents elected to forgo the vaccines and a controversy erupted

Vaxxed captured international headlines last year after it was "de-selected" from the Tribeca Film Festival due to pressure put on the festival's organizers from sponsors with connections to the pharmaceutical industry. Despite numerous attempts at incorrectly labeling the film as "anti-vaccine" and overt censorship from festivals and media outlets, the film was released theatrically in over 60 U.S and Canadian cities, with an additional 500 screening events, has grossed over $1.2 million at the box office and sold tens of thousands of DVDs and digital streams. The filmmakers have been touring the nation by bus, (the Vaxxed tour), and have recorded nearly ten thousand vaccine injury stories. Since widening its release, the film has also experienced organized censorship in Italy and Australia.

Robert DeNiro, one of Tribeca Film Festival's founders, who originally advocated for the film, famously said on national television, "I think the movie is something that people should see."

MEDIA CONTACT:
Jamie Coker Robertson
[email protected]

Beth Portello, Cinema Libre Studio
[email protected]
818-588-3033

FILM LINKS:

www.vaxxedthemovie.com | @vaxxedthemovie | facebook.com/vaxxedthemovie

RELATED COVERAGE:

http://www.today.com/popculture/robert-deniro-debates-autism-s-link-vaccines-today-show-t86136

Additional coverage can be found here: HTTP://VAXXEDTHEMOVIE.COM/PRESS/

Related Video

https://vimeo.com/159566038

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com.

SOURCE Cinema Libre Studio

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.